Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer

International Journal of Cancer

Volumn 77, Issue 4, 1998, Pages 522-527

  Nozawa, Hiroaki ^a   Oda, Eri ^a   Ueda, Seiji ^a   Tamura, Gen ^b   Maesawa, Chihaya ^b   Muto, Tetsuichiro ^a   Taniguchi, Tadatsugu ^a   Tanaka, Nobuyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CELL CYCLE; CHROMOSOME 5Q; CONTROLLED STUDY; GENE LOCUS; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

3T3 CELLS; ANIMALS; CELL CYCLE; CHROMOSOMES, HUMAN, PAIR 5; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; INTERFERON REGULATORY FACTOR-1; LOSS OF HETEROZYGOSITY; MICE; PHOSPHOPROTEINS; POINT MUTATION; STOMACH NEOPLASMS;

EID: 0031823904     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980812)77:4<522::AID-IJC8>3.0.CO;2-W     Document Type: Article

References (20)

1. BISHOP, J.M., Molecular themes in oncogenesis. Cell, 64, 235-248 (1991).
2. HARADA, H., KONDO, T., OGAWA, S., TAMURA, T., KITAGAWA, M., TANAKA, N., LAMPHIER, M.S., HIRAI, H. and TANIGUCHI, T., Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation. Oncogene, 9, 3313-3320 (1994).
3. HARADA, H., WILLISON, K., SAKAKIBARA, J., MIYAMOTO, M., FUJITA, T. and TANIGUCHI, T., Absence of the type-I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell. 63, 303-312 (1990).
4. HORII, A., NAKATSURU, S., MIYOSHI, Y., ICHII, S., NAGASE, H., KATO, Y., YANAGISAWA, A. and NAKAMURA, Y., The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res., 52, 3231-3233 (1992).
5. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER (ed.), Japanese classification of gastric carcinoma (1st ed.), Kanehara, Tokyo (1995).
6. KNUDSON, A.G., Mutation and cancer: statistical study of retinoblastoma. Proc. nat. Acad. Sci. (Wash.), 68, 820-823 (1971).
7. KONDO, T., MINAMINO, N., NAGAMURA-INOUE, T., MATSUMOTO, M., TANIGUCHI, T. and TANAKA, N., Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene, 15, 1275-1281 (1997).
8. MORGENSTERN, J.P. and LAND, H., Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug-selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18, 3587-3596 (1990).
9. PEAR, W.S., NOLAN, G.P., SCOTT, M.L. and BALTIMORE, D., Production of high-titer helper-free retroviruses by transient transfection. Proc. nat. Acad. Sci. (Wash.), 90, 8392-8396 (1993).
10. POWELL, S.M., CUMMINGS, O.W., MULLEN, J.A., ASGHAR, A., FUGA, G., PIVA, P., MINACCI, C., MEGHA, T., TOSI, P. and JACKSON, C.E., Characterization of the APC gene in sporadic gastric adenocarcinomas. Oncogene, 12, 1953-1959 (1996).
11. SHARF, R., MERARO, D., AZRIEL, A., THORNTON, A.M., OZATO, K., PETRICOIN, E.F., LARNER, A.C., SCHAPER, F., HAUSER, H. and LEVI, B.Z., Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J. biol. Chem., 272, 9785-9792 (1997).
12. SOLOMON, E., BORROW, J. and GODDARD, A.D., Chromosome aberrations and cancer. Science, 254, 1153-1160 (1991).
13. TAHARA, E., Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer, 75, 1410-1417 (1995).
14. TAMURA, G., OGASAWARA, S., NISHIZUKA, S., SAKATA, K., MAESAWA, C., SUZUKI, Y., TERASHIMA, M., SAITO, K. and SATODATE, R., Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res., 56, 612-615 (1996).
15. TAMURA, T., ISHIHARA, M., LAMPHIER, M.S., TANAKA, N., OISHI, I., AIZAWA, S., MATSUYAMA, T., MAK, T.W., TAKI, S. and TANIGUCHI, T., An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature (Lond.), 376, 596-599 (1995).
16. TANAKA, N., ISHIHARA, M., KITAGAWA, M., HARADA, H., KIMURA, T., MATSUYAMA, T., LAMPHIER, M.S., AIZAWA, S., MARK, T.W. and TANIGUCHI, T., Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell, 77, 829-839 (1994).
17. TANAKA, N., ISHIHARA, M., LAMPHIER, M.S., NOZAWA, H., MATSUYAMA, T., MAK, T.W., AIZAWA, S., TOKINO, T., OREN, M. and TANIGUCHI, T., Cooperation of the tumor suppressors IRF-1 and p53 in response to DNA damage. Nature (Lond.), 382, 816-818 (1996).
18. TANIGUCHI, T., LAMPHIER, M.S. and TANAKA, N., IRF-1; the transcription factor linking the interferon response and oncogenesis. Biochim.biophys. Acta, Reviews on Cancer, 1333, M9-M17 (1997).
19. VOGELSTEIN, B. and KINZLER, K.W., The multistep nature of cancer. Trends Genet., 9, 138-141 (1993).
20. WEINBERG, R.A., The molecular basis of oncogenes and tumor suppressor genes. Ann. N.Y. Acad. Sci., 758, 331-338 (1995).